Analyst Perspective:
Germany breast cancer therapeutics market accounted for US$ XX Mn in 2022, and it is expected to grow at a CAGR of 9.5% during the period 2022 - 2030, to reach US$ XX Mn in 2030.
As per Globocan 2020, about 69,697 new instances of breast cancer were reported in 2020 in Germany, representing 11.1% of all registered cancer cases. It caused 20,579 fatalities, and the five-year prevalence rate of breast cancer in all ages was 707.38 per 100,000 population. Breast cancer treatment costs almost US$ 2.13 billion (2 billion euros) annually. According to the German Cancer Society, one in eight women will have breast cancer during their lifetime.
Numerous businesses run various programs to assist with breast cancer screenings, which can result in offering better treatment to the individual. For instance, in and around Paderborn, Germany, Radiologie am Theater has three special breast cancer diagnostic facilities. According to the center, more than 15,000 breast exams are performed annually in the country. In addition, women aged 50–69 can have a free mammogram every two years in the country. This helps detect breast cancer as early as possible to provide better treatment and increase the chances of recovery.
On the occasion of breast cancer awareness month in October, a unique campaign was initiated to shed light on the disease in October 2021. The campaign “Breast Cancer Affects Us All” has been created by Wefra Life, an advertising agency and a non-profit association Pink Ribbon Germany.
In June 2020, Vara, a Berlin-based company, aimed to save lives by making breast cancer screening accessible worldwide. It raised US$ 7.31 million (Euro 6.5 million) in a Series A funding round led by OMERS Ventures for AI-powered breast cancer screening software. Therefore, the growing disease burden is anticipated to promote the breast cancer therapeutics demand, along with its rising awareness in the country.
Market Segmentation - Breast Cancer Therapeutics Market
SEGMENT NAME | TYPE |
Drug Therapy | Targeted Drug Therapy, Hormonal Drug Therapy, Chemotherapy, Immunotherapy/ Biological therapy |
Targeted Drug Therapy | Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, Other Targeted Drug Therapy |
Hormonal Drug Therapy | Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Selective Estrogen Receptor Downregulators (SERDs) |
Breast Cancer Type | Hormone Receptor, HER2+ (human epidermal growth factor receptor 2), Triple-Negative Breast Cancer |
Distribution Channel | Hospital Pharmacies, Drug Store and Retail Pharmacies, Online Pharmacies |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Key Player Analysis - Breast Cancer Therapeutics Market
- Eli Lilly and Co,
- Eisai Co Ltd
- Novartis AG
- AstraZeneca Plc
- Pfizer Inc
- Gilead Sciences Inc
- Merck & Co Inc
- Genentech Inc
- Teva Pharmaceutical Industries Ltd
- Amgen Inc
are the key Breast Cancer Therapeutics Market players profiled in the report.
The List of Companies - Breast Cancer Therapeutics Market
- Eli Lilly and Co,
- Eisai Co Ltd
- Novartis AG
- AstraZeneca Plc
- Pfizer Inc
- Gilead Sciences Inc
- Merck & Co Inc
- Genentech Inc
- Teva Pharmaceutical Industries Ltd
- Amgen Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.